The impact of implementation of a hysterectomy enhanced recovery pathway on anesthetic medication costs

Austin D. Street, Jennifer M. Elia, Mandy M. McBroom, Allan J. Hamilton, Jessica E. Grundt, James Michael N. Blackwell, Bryan T. Romito

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: To evaluate the effect of implementation of a hysterectomy Enhanced Recovery After Surgery (ERAS) protocol on perioperative anesthetic medication costs. Patients & methods: Historical cohort study of 84 adult patients who underwent a hysterectomy. Forty-two patients who underwent surgery before protocol implementation comprised the pre-ERAS group. Forty-two patients who underwent surgery after protocol implementation comprised the post-ERAS group. Data on anesthetic medication costs and outcomes were analyzed. Results: Compared with the pre-ERAS group, the post-ERAS group's total medication cost was significantly lower (median: 325.20 USD; interquartile range [IQR]: 256.12-430.65 USD vs median: 273.10 USD; IQR: 220.63-370.59 USD, median difference:-40.76, 95% CI:-130.39, 16.99, p = 0.047). Length of stay was significantly longer in pre-ERAS when compared with post-ERAS groups (median: 5.0 days; IQR: 4.0-7.0 days vs median: 3.0 days; IQR: 3.0-4.0 days, median difference:-2.0 days, 95% CI:-2.5581,-1.4419, p < 0.0001). Conclusion: ERAS protocols may reduce perioperative medication costs.

Original languageEnglish (US)
Pages (from-to)1067-1077
Number of pages11
JournalJournal of Comparative Effectiveness Research
Volume9
Issue number15
DOIs
StatePublished - Oct 15 2020

Keywords

  • anesthesia
  • cost savings
  • drug costs
  • economics
  • perioperative care
  • pharmaceutical

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'The impact of implementation of a hysterectomy enhanced recovery pathway on anesthetic medication costs'. Together they form a unique fingerprint.

Cite this